NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Dynamk Capital

Dynamk Capital

New York City, New Yorkdynamk.vc

Overview

Dynamk Capital is a venture capital firm that invests in early-stage (Seed through Series B) companies developing innovative tools, technologies, and services for the Life Sciences industry. The firm focuses on the underlying technologies that are critical for the discovery, development, and manufacturing of biotherapeutics.

Portfolio Companies

10

Website

dynamk.vc

Investments

Dynamk Capital investments
CompanyDateStageLead
Alpenglow BiosciencesAug 2024VC RoundLead
CellFESep 2023Series ACo-investor
Lucid ScientificSep 2023Series ACo-investor
Vernal BiosciencesJun 2023Series A ExtensionCo-investor
Vernal BiosciencesJun 2022VC RoundLead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.